The health and economic burden of rotavirus disease in Belgium

European Journal of Pediatrics

Volumn 167, Issue 12, 2008, Pages 1409-1419

  Bilcke, Joke ^a   Van Damme, Pierre ^a   De Smet, Frank ^b   Hanquet, Germaine ^c   Van Ranst, Marc ^d   Beutels, Philippe ^a,e  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b National Alliance of Christian Sickness Funds   (Belgium)

^c SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^d REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Burden; Cost; Rotavirus

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; BELGIUM; CHILD; CHILD HOSPITALIZATION; CHILDHOOD MORTALITY; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HEALTH SURVEY; HOSPITAL COST; HOSPITAL INFECTION; HUMAN; INFANT; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OUTPATIENT CARE; PEDIATRICIAN; PRIORITY JOURNAL; ROTAVIRUS; VACCINATION; VIRAL GASTROENTERITIS; VIRUS INFECTION;

BELGIUM; CAREGIVERS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COST OF ILLNESS; GASTROENTERITIS; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; OFFICE VISITS; ROTAVIRUS INFECTIONS;

EID: 54349084123     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-008-0684-3     Document Type: Article

References (40)

1. ZebraZone European Research & Service Center, Het absenteïsme in België (2005) ( http://www.zebrazone.be/ZebraZine/ZZineTXT/attach/ White%20Paper%20Absenteisme%202005%20NL%20GRH.pdf )
2. EC Araujo SA Clemens CS Oliveira MC Justino P Rubio YB Gabbay VB Silva JD Mascarenhas VL Noronha R Clemens RH Gusmao N Sanchez TA Monteiro AC Linhares 2007 Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy infants J Pediatr (Rio J) 83 3 217 224
3. Beutels P, Van Damme P, Oosterhuis-Kafeja F (2006) Effects and costs of pneumococcal conjugate vaccination of Belgian children. KCE reports vol33C http://www.kce.fgov.be/index_en.aspx?SGREF=5220&CREF=8068 )
4. P Beutels P Van Damme V Van Casteren NJ Gay K De Schrijver A Meheus 2002 The difficult quest for data on "vanishing" vaccine-preventable infections in Europe: the case of measles in Flanders (Belgium) Vaccine 20 29-30 3551 3559
5. Bilcke J, Beutels P, De Smet F, Hanquet G, Van Ranst M, Van Damme P (2007) Cost-effectiveness analysis of rotavirus vaccination of Belgian infants. KCE reports vol54C http://www.kce.fgov.be/index_en.aspx?ID=0&SGREF= 9152&CREF=9405 )
6. Bilcke J, Van Damme P, Beutels P Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and 'no medical care' disease impact in Belgium. submitted
7. SL Block T Vesikari MG Goveia SB Rivers BA Adeyi MJ Dallas J Bauder JW Boslego PM Heaton 2007 Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life Pediatrics 119 1 11 18
8. Briggs A, Claxton K, Sculpher M (2006) Decision modelling for health economic evaluation. Oxford University Press, New York
9. I de Zoysa RG Feachem 1985 Interventions for the control of diarrhoeal diseases among young children: rotavirus and cholera immunization Bull W H O 63 3 569 583
10. PH Dennehy 2007 Rotavirus vaccines-an update Vaccine 25 16 3137 3141
11. M Fruhwirth U Heininger B Ehlken G Petersen B Laubereau I Moll-Schuler I Mutz J Forster 2001 International variation in disease burden of rotavirus gastroenteritis in children with community- and nosocomially acquired infection Pediatr Infect Dis J 20 8 784 791
12. C Giaquinto P Van Damme F Huet L Gothefors M Van der Wielen 2007 Costs of community-acquired pediatric rotavirus gastroenteritis in 7 European countries: The REVEAL Study J Infect Dis 195 Suppl 1 S36 S44
13. RI Glass UD Parashar JS Bresee R Turcios TK Fischer MA Widdowson B Jiang JR Gentsch 2006 Rotavirus vaccines: current prospects and future challenges Lancet 368 9532 323 332
14. O Gleizes U Desselberger V Tatochenko C Rodrigo N Salman Z Mezner C Giaquinto E Grimprel 2006 Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease Pediatr Infect Dis J 25 1 Suppl S12 S21
15. M Gurwith W Wenman D Hinde S Feltham H Greenberg 1981 A prospective study of rotavirus infection in infants and young children J Infect Dis 144 3 218 224
16. JP Harris M Jit D Cooper WJ Edmunds 2007 Evaluating rotavirus vaccination in England and Wales Part I. Estimating the burden of disease Vaccine 25 20 3962 3970
17. PK Lorgelly D Joshi M Iturriza Gomara C Flood CA Hughes J Dalrymple J Gray M Mugford 2007 Infantile gastroenteritis in the community: a cost-of-illness study Epidemiol Infect 136 1 34 43
18. PK Lorgelly D Joshi M Iturriza Gómara J Gray M Mugford 2007 Exploring the cost-effectiveness of an immunisation programme for rotavirus gastroenteritis in the United Kingdom Epidemiol Infect 136 1 44 55
19. Newall AT, Beutels P, Macartney K, Wood J, MacIntyre R (2007) The cost-effectiveness of rotavirus vaccination in Australia. Vaccine 25(52):8851-8860
20. AT Newall R MacIntyre H Wang B Hull K Macartney 2006 Burden of severe rotavirus disease in Australia J Paediatr Child Health 42 9 521 527
21. UD Parashar EG Hummelman JS Bresee MA Miller RI Glass 2003 Global illness and deaths caused by rotavirus disease in children Emerg Infect Dis 9 5 565 572
22. KB Phua SH Quak BW Lee SC Emmanuel P Goh HH Han B De Vos HL Bock 2005 Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants J Infect Dis 192 Suppl 1 S6 S16
23. E Piednoir K Bessaci F Bureau-Chalot P Sabouraud V Brodard L Andreoletti O Bajolet 2003 Economic impact of healthcare-associated rotavirus infection in a paediatric hospital J Hosp Infect 55 3 190 195
24. M Raes P Aerssens P Alliet P Gillis MP Verjans A Mewis 2008 Rotavirus gastroenteritis: epidemiological data from a regional hospital in Belgium Eur J Pediatr 167 1 71 73
25. WJ Rodriguez HW Kim CD Brandt RH Schwartz MK Gardner B Jeffries RH Parrott RA Kaslow JI Smith AZ Kapikian 1987 Longitudinal study of rotavirus infection and gastroenteritis in families served by a pediatric medical practice: clinical and epidemiologic observations Pediatr Infect Dis J 6 2 170 176
26. GM Ruiz-Palacios I Perez-Schael FR Velazquez H Abate T Breuer SC Clemens B Cheuvart F Espinoza P Gillard BL Innis Y Cervantes AC Linhares P Lopez M Macias-Parra E Ortega-Barria V Richardson DM Rivera-Medina L Rivera B Salinas N Pavia-Ruz J Salmeron R Ruttimann JC Tinoco P Rubio E Nunez ML Guerrero JP Yarzabal S Damaso N Tornieporth X Saez-Llorens RF Vergara T Vesikari A Bouckenooghe R Clemens B De Vos M O'Ryan 2006 Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis N Engl J Med 354 1 11 22
27. B Salinas I Perez Schael AC Linhares GM Ruiz Palacios ML Guerrero JP Yarzabal Y Cervantes S Costa Clemens S Damaso K Hardt B De Vos 2005 Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infants Pediatr Infect Dis J 24 9 807 816
28. M Soriano-Gabarro J Mrukowicz T Vesikari T Verstraeten 2006 Burden of rotavirus disease in European Union countries Pediatr Infect Dis J 25 1 Suppl S7 S11
29. S Stebbins 2007 Rotavirus: disease and vaccine update, 2007 J Fam Pract 56 2 Suppl Vaccines S6 S11
30. A Thuret H Patural P Berthelot F Benzait I Martin JF Jusot G Teyssier J Fabry B Pozzetto 2004 Prospective follow-up of hospital-acquired diarrhoea in 28 paediatric wards of the south-east part of France during a winter season Pathol Biol (Paris) 52 3 131 137
31. Van Casteren V, Bossuyt N (2002) Survey site visit Belgium July 15th 2002. Belgian Sentinel Network of General Practitioners
32. P Van Damme C Giaquinto F Huet L Gothefors M Maxwell M Van der Wielen 2007 Multicenter Prospective Study of the Burden of Rotavirus Acute Gastroenteritis in Europe, 2004-2005: The REVEAL Study J Infect Dis 195 Suppl 1 S4 S16
33. P Van Damme M Van der Wielen F Ansaldi D Desgrandchamps JD Domingo FG Sanchez J Gray M Haditsch K Johansen P Lorgelly M Lorrot N Parez V Reschke M Rose 2006 Rotavirus vaccines: considerations for successful implementation in Europe Lancet Infect Dis 6 12 805 812
34. Vandenberghe H Estimation de la représentativité nationale du réseau des laboratoires vigies. Proceedings of the 20th seminary "Diagnosis and surveillance of infectious diseases" SIPH 2004:19-27 http://www.iph.fgov.be/epidemio/epifr/plabfr/semfr/sem20.pdf )
35. FR Velazquez DO Matson JJ Calva L Guerrero AL Morrow S Carter-Campbell RI Glass MK Estes LK Pickering GM Ruiz-Palacios 1996 Rotavirus infections in infants as protection against subsequent infections N Engl J Med 335 14 1022 1028
36. T Vesikari HF Clark PA Offit MJ Dallas DJ DiStefano MG Goveia RL Ward F Schodel A Karvonen JE Drummond MJ DiNubile PM Heaton 2006 Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants Vaccine 24 22 4821 4829
37. T Vesikari A Karvonen R Prymula V Schuster JC Tejedor R Cohen F Meurice HH Han S Damaso A Bouckenooghe 2007 Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study Lancet 370 9601 1757 1763
38. T Vesikari A Karvonen L Puustinen SQ Zeng ED Szakal A Delem B De Vos 2004 Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants Pediatr Infect Dis J 23 10 937 943
39. T Vesikari DO Matson P Dennehy P Van Damme M Santosham Z Rodriguez MJ Dallas JF Heyse MG Goveia SB Black HR Shinefield CD Christie S Ylitalo RF Itzler ML Coia MT Onorato BA Adeyi GS Marshall L Gothefors D Campens A Karvonen JP Watt KL O'Brien MJ DiNubile HF Clark JW Boslego PA Offit PM Heaton 2006 Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine N Engl J Med 354 1 23 33
40. MA Widdowson MI Meltzer X Zhang JS Bresee UD Parashar RI Glass 2007 Cost-effectiveness and potential impact of rotavirus vaccination in the United States Pediatrics 119 4 684 697